A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anthony Kong, MBBS
Guy's and St Thomas' NHS Foundation Trust
Principal Investigator - Benedict Panizza, MBBS MBA
Metro South Hospital and Health Service, via the Princess Alexandra Hospital
Principal Investigator - David Owens, MBchB
Cardiff and Vale University Health Board - University Hospital of Wales (UHW)
Principal Investigator - George Mochloulis, MD CCST
East and North Hertfordshire NHS Trust (Incorporating Mount Vernon Cancer Centre) of Lister Hospital
Principal Investigator - Joseph Sacco, MBchB
The Clatterbridge Cancer Centre NHS Foundation Trust
Principal Investigator - Kevin Harrington, BSc MBBS
Royal Marsden NHS Foundation Trust
Principal Investigator - Richard Gallagher, MBBS
The Kinghorn Cancer Centre
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the Kinghorn Cancer Centre
Sydney, New South Wales, Australia
- Metro South Hospital and Health Service, Via the Princess Alexandra Hospital
Brisbane, Queensland, Australia
- Cardiff and Vale University Health Board - University Hospital of Wales (uhw)
Cardiff, Cardiff, United Kingdom
- East and North Hertfordshire Nhs Trust (incorporating Mount Vernon Cancer Centre) of Lister Hospital
Stevenage, Hertfordshire, United Kingdom
- the Clatterbridge Cancer Centre Nhs Foundation Trust
Bebington, Wirral, United Kingdom
- Guy'S and St Thomas' Nhs Foundation Trust
London, United Kingdom
- the Royal Marsden Nhs Foundation Trust
London, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 3 Nov 2022
- Primary completion
- 31 Jul 2025
- Completion
- 31 Aug 2026
- Last update posted
- 7 Aug 2025
- Registered enrollment
- 15
- Registry id
- NCT05608876
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.